1. Home
  2. SFST vs IPSC Comparison

SFST vs IPSC Comparison

Compare SFST & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern First Bancshares Inc.

SFST

Southern First Bancshares Inc.

HOLD

Current Price

$60.69

Market Cap

527.0M

Sector

Finance

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.22

Market Cap

441.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFST
IPSC
Founded
1999
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
527.0M
441.9M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
SFST
IPSC
Price
$60.69
$2.22
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$64.00
$4.25
AVG Volume (30 Days)
104.6K
902.3K
Earning Date
04-21-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
94.76
91.30
EPS
1.19
N/A
Revenue
$6,282,000.00
$109,164,000.00
Revenue This Year
$10.47
N/A
Revenue Next Year
$12.19
N/A
P/E Ratio
$50.18
N/A
Revenue Growth
12.99
1556.76
52 Week Low
$34.93
$0.44
52 Week High
$62.00
$2.97

Technical Indicators

Market Signals
Indicator
SFST
IPSC
Relative Strength Index (RSI) 65.90 48.41
Support Level $53.96 $2.13
Resistance Level $61.53 $2.45
Average True Range (ATR) 1.71 0.16
MACD 0.33 -0.01
Stochastic Oscillator 85.08 43.12

Price Performance

Historical Comparison
SFST
IPSC

About SFST Southern First Bancshares Inc.

Southern First Bancshares Inc is a bank holding company. Through its banking subsidiary, it is engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer, and mortgage loans, ATM processing, and other banking products and services to the general public. The group operates through various retail offices located in the Greenville, Columbia, and Charleston markets of South Carolina, three retail offices in the Raleigh, Greensboro, and Charlotte markets of North Carolina, and one retail office in Atlanta, Georgia.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Share on Social Networks: